본문바로가기
Q
U
I
C
K

Global Innovative Partner of Vaccine and Biotech SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

Our Science & Technology

Conducting research into vaccines that will be the driving force in the life science business going forward.

The world's best vaccine factory with advanced vaccine technology.

Leading in expanding the global market through cooperation with global companies.

What’s New

  • SK bioscience News SK bioscience Receives Approval for...

    -SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials in Australia in F...

    More
  • News SK bioscience Receives Approva...

    This approval paves the way for exports to the wor...

    More
  • News SK bioscience Acquires Stake i...

    SK bioscience invested USD 3 million in FinaBio, a...

    More
  • News SK bioscience Completes Acquis...

    SK bioscience completed the acquisition of German ...

    More
  • News SK bioscience and CEPI Deepen ...

    -The Coalition for Epidemic Preparedness Innovatio...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products

  • SKYCovione™
  • SKYCellflu® Quadrivalent Prefilled Syringe
  • SKYZoster®
  • SKYVaricella®




PRODUCTS SKYCovione™
SKYCovione Multi Inj. image

[13494] 310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
Company Registration Number 818-86-00991

Copyright(c) SK bioscience. All Right Reserved

접근성 마크
  GO